Assignee
PROTEIN DESIGN LABS INC
US·28 granted patents·12 pending applications·31,430 citations·filing 1987–2007
Top patents by PatentIndex Score
40 records- 0199US6350861B1Antibodies with increased binding affinityPROTEIN DESIGN LABS INC·Filed 1997·Granted Feb 26, 2002·1.1k cites·16 claims
- 0299US6180370B1Humanized immunoglobulins and methods of making the samePROTEIN DESIGN LABS INC·Filed 1995·Granted Jan 30, 2001·3.6k cites·30 claims
- 0399US5714350AIncreasing antibody affinity by altering glycosylation in the immunoglobulin variable regionPROTEIN DESIGN LABS INC·Filed 1995·Granted Feb 3, 1998·1.2k cites·16 claims
- 0499US5585089AHumanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 1995·Granted Dec 17, 1996·7.5k cites·11 claims
- 0599US5530101AHumanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 1990·Granted Jun 25, 1996·5.8k cites·13 claims
- 0698US7022500B1Humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 2000·Granted Apr 4, 2006·172 cites·95 claims
- 0798US6329511B1Humanized antibodies to γ-interferonPROTEIN DESIGN LABS INC·Filed 1999·Granted Dec 11, 2001·308 cites·8 claims
- 0898US6210671B1Humanized antibodies reactive with L-selectinPROTEIN DESIGN LABS INC·Filed 1995·Granted Apr 3, 2001·274 cites·17 claims
- 0998US5777085AHumanized antibodies reactive with GPIIB/IIIAPROTEIN DESIGN LABS INC·Filed 1995·Granted Jul 7, 1998·274 cites·17 claims
- 1098US5693762AHumanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 1995·Granted Dec 2, 1997·5.3k cites·20 claims
- 1198US5693761APolynucleotides encoding improved humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 1995·Granted Dec 2, 1997·3.3k cites·21 claims
- 1298US5349053AChimeric ligand/immunoglobulin molecules and their usesPROTEIN DESIGN LABS INC·Filed 1993·Granted Sep 20, 1994·590 cites·12 claims
- 1396US6682890B2Methods of diagnosing and determining prognosis of colorectal cancerPROTEIN DESIGN LABS INC·Filed 2001·Granted Jan 27, 2004·108 cites·4 claims
- 1496US5834597AMutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the samePROTEIN DESIGN LABS INC·Filed 1996·Granted Nov 10, 1998·499 cites·18 claims
- 1595US5622701ACross-reacting monoclonal antibodies specific for E- and P-selectinPROTEIN DESIGN LABS INC·Filed 1994·Granted Apr 22, 1997·141 cites·12 claims
- 1694US5932448ABispecific antibody heterodimersPROTEIN DESIGN LABS INC·Filed 1991·Granted Aug 3, 1999·576 cites·16 claims
- 1793US6210670B1Cross-reacting monoclonal antibodies specific for E-selectin and P-selectinPROTEIN DESIGN LABS INC·Filed 1995·Granted Apr 3, 2001·107 cites·55 claims
- 1893US5882644AMonoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereofPROTEIN DESIGN LABS INC·Filed 1996·Granted Mar 16, 1999·121 cites·13 claims
- 1992US6762020B1Methods of diagnosing breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Jul 13, 2004·51 cites·6 claims
- 2092US6129914ABispecific antibody effective to treat B-cell lymphoma and cell linePROTEIN DESIGN LABS INC·Filed 1995·Granted Oct 10, 2000·195 cites·28 claims
- 2191US6750013B2Methods for detection and diagnosing of breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Jun 15, 2004·48 cites·8 claims
- 2289US6013256AMethod of preventing acute rejection following solid organ transplantationPROTEIN DESIGN LABS INC·Filed 1997·Granted Jan 11, 2000·85 cites·23 claims
- 2387US6046310AFAS ligand fusion proteins and their usesPROTEIN DESIGN LABS INC·Filed 1997·Granted Apr 4, 2000·58 cites·8 claims
- 2484US6780586B1Methods of diagnosing breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Aug 24, 2004·24 cites·8 claims
- 2582US5004692ACloning and expression of phosopholipase C genesPROTEIN DESIGN LABS INC·Filed 1987·Granted Apr 2, 1991·43 cites·18 claims
- 2681US5216132ASoluble t-cell antigen receptor chimeric antigensPROTEIN DESIGN LABS INC·Filed 1990·Granted Jun 1, 1993·54 cites·6 claims
- 2770US6894149B2Anti-HLA-DA antibodies and the methods of using thereofPROTEIN DESIGN LABS INC·Filed 2002·Granted May 17, 2005·13 cites·13 claims
- 2868US2008175839A1Compositions Against Cancer Antigen LIV-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 2964US2008171039A1Compositions Against Cancer Antigen Liv-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 3062US2004141983A1Compositions against cancer antigen LIV-1 and uses thereofPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 3159US2005025763A1Therapeutic use of anti-CS1 antibodiesPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 3258US2004115814A1Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genesPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 3358US2004052783A1Humanized antibodies against CD3PROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 3457US2008025975A1Humanized antibodies against cd3PROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 3556US2004253606A1Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulatorsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 3655US2003229208A1Humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 3755US2004049014A1Humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 3849US2005019323A1Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodiesPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 3938US6410824B1Animal model for psoriasis for the prevention and treatment of psoriasis in humansPROTEIN DESIGN LABS INC·Filed 1999·Granted Jun 25, 2002·5 cites·13 claims
- 4038US2006008415A1Stable liquid and lyophilized formulation of proteinsPROTEIN DESIGN LABS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROTEIN DESIGN LABS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →